Walter Narajowski

President & Founder LabDx, Board Member Nuclein LLC.

About

Currently President and founder of LabDx LLC and Board Member of Nuclein LLC. I have over 25 years of senior level experience combining technical, commercial, business strategy and organizational development building high growth businesses with in the Diagnostic and Medical Device Industries. Previous Chief Operating Officer Minute Molecular Diagnostics - 15 minute point-of-care PCR system. Lead Minute Molecular to successful COVID EUA and merger with Nuclein LLC. Previous member of the Board of Directors of MDxHealth Inc. (MDXH:EURONEXT) and Chair of the Renumeration Committee, a molecular liquid biopsy company focused in Urology Sr. Vice President and General Manager for Roka Bioscience (ROKA:NASDAQ) from 2009 until 2014, a molecular diagnostic company serving the Food Safety Industry. President/C.E.O. and Board Member of Pathway Diagnostics a biomarker development and testing company from 2005 until it was sold to Quest Diagnostics in 2008. Vice President & General Manager of Focus Diagnostics, an Infectious Disease Reference Laboratory and Diagnostic Product business. The majority of my career was with Abbott Laboratories where I served as Vice President and General Manager of Critical Care Products (1995-98), Vice President and General Manager of the Infusion Pump business (1990-95). Prior to 1990, I was in the Diagnostic's Division where I was General Manager of Physician Office Diagnostics, as well as a Director of R&D with leading roles in the development of the Vision whole blood chemistry system, TDx System and Quantum analyzer. Specialities: Executive Management In-Vitro Diagnostic Products, Point of Care Diagnostics, Laboratory Services, Laboratory Developed Tests Entrepreneurship, Business/Market/Technical Analysis Business Strategy R&D, Product Development & Product Launch P&L management Technology Licensing Operations (product or services) GLP, GMP. ISO, FDA product approval Turn around management Private Equity

Country

City

United States

Industry

Hospital & Health Care

Skill

Biotechnology, Lifesciences, Medical Devices, Cross-functional Team Leadership, R&D, Commercialization, Product Development, Genomics, Molecular Biology, Technology Transfer, Assay Development, Immunology, FDA, DNA, Strategic Planning, Microfluidics, Microbiology, Leadership, Entrepreneurship, Business Strategy

Experience

President & Founder LabDx, Board Member Nuclein LLC.

LabDx l.l.c.

2023-3 - Present · 3 yrs 7 mos

Morrison, Colorado, United States

Lead Partner establishing business relationships within the Diagnostic Industry. Provide strategic advise and operational partnerships with Senior Executive Management and Private Equity focusing on the In-Vitro Diagnostic Product & Laboratory Testing Industry.

Partner at LabDx and Chief Operating Officer at Minute Molecular

LabDx and Minute Molecular Diagnostics

2016-3 - 2023-3 · 7 yrs 1 mo

LabDx partners with Senior Management and investors providing business strategy, product portfolio, commercialization and operational excellence services for Point of Care testing and laboratory services. Key activities during this time: Board Member MDxHealth (prostate cancer laboratory service company); Business strategy/product portfolio advise for Sepsis POC immunoassay platform, Part-time Chief Operating Officer for Minute Molecular Diagnostics - Rapid 15 minute PCR POC testing technology which received $21M NIH contract for technology commercialization receiving SARS CoV-2 authorization in March 2022. Lead strategic alternative process completing Minute Molecular merger with Nuclein llc in March 2023.

SVP & GM

Roka Bio

2009-9 - 2015-12 · 6 yrs 4 mos

San Diego

Molecular Diagnostic business developing automated RNA assays for Salmonella, listeria and O157:H7 based on Gen-Probe technology. San Diego site Leadership for R&D, Manufacturing, Quality, Distribution and Service. Started with 18 people from Gen-Probe, building out 50,000 sq.ft. facility scaling to 75 people and successfully introducing seven molecular assays on an automated platform

President/CEO and Board Member

Pathway Diagnostics

2005-9 - 2008-12 · 3 yrs 4 mos

Biomarker esoteric clinical trial testing laboratory supporting biopharmaceutical drug development & companion diagnostics. Pathway leveraged its testing laboratory by licensing proprietary biomarkers and developing them into companion diagnostics. Pathway was purchased by Quest Diagnostics in December 2008.

Vp & GM

Focus Diagnostics

2000 - 2005 · 5 yrs

Infectious disease reference laboratory and diagnostic product company. Responsible for business turn around from < 3% annual sales growth to > 15% average sales growth 2000-2005. Operating income grew 27% compounded during the same period. Responsible for leading business strategy, creating a diagnostic product strategy, re-aligning and expanding the sales organization, streamlining operations, establishing strategic direction and accountability for R&D programs. Introduced multiple FDA 510K cleared products and greater than 50 LDT tests.

General Partner

White Eagle Investments

1998 - 2000 · 2 yrs

San Jose

Private investment fund manager and start-up consultant. Primary focus was technology, medical products and genomics.

VP& GM Abbott Critical Care

Abbott Laboratories

1995 - 1998 · 3 yrs

San Jose

$400 million fully integrated business unit with product lines in patient monitoring, cardiac output measurement, cath lab accessories and drug delivery infusion pumps for home and hospital.

VP & GM Electronic Delivery Systems

Abbott Laboratories

1990 - 1995 · 5 yrs

Abbott Park

General Manager of Abbott's infusion pump business

General Manager Vision Business Unit

Abbott

1985 - 1990 · 5 yrs

Abbott Park

Introduced whole blood chemistry in-vitro testing system for the physician office. Grew business to $100M, #1market share with over 10,000 instruments placed.